Ambrisentan Ethyl Ester Racemate

Ambrisentan Ethyl Ester Racemate or 2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenyl propanoic acid ethyl ester, is used in the treatment of pulmonary arterial hypertension and is a selective endothelin receptor antagonist.

Additional information

Catalogue No.

VE007947

CAS No.

N/A

Molecular Formula

C24H26N2O4

Molecular Weight

406.47 g/mo

IUPAC Name

2-[(4, 6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3, 3-diphenyl propanoic acid ethyl ester

References

Rivera-Lebron, Belinda N., and Michael G. Risbano. “Ambrisentan: A Review of Its Use in Pulmonary Arterial Hypertension.” Therapeutic Advances in Respiratory Disease, vol. 11, no. 6, 20 Apr. 2017, pp. 233–244, 10.1177/1753465817696040.

Status

In-stock